HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
50 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
Chromosome 1 · 1p32.1
NCBI Gene: 3725Ensembl: ENSG00000177606.9HGNC: HGNC:6204UniProt: P05412
1,326PubMed Papers
20Diseases
0Drugs
1Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneOncogeneTranscription Factor
RESEARCH IMPACT
Highly Studied
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
DNA-binding transcription factor activity, RNA polymerase II-specifictranscription cis-regulatory region bindingRNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA-binding transcription repressor activity, RNA polymerase II-specificneurodegenerative diseasecancerAlzheimer diseasecolon adenocarcinoma
✦AI Summary

JUN is a proto-oncogene encoding an AP-1 transcription factor subunit that functions as a DNA-binding transcription regulator with both activating and repressing roles in gene expression 1. JUN operates as a key mediator linking oxidative stress to steroidogenesis through AP-1 signaling, where its phosphorylation and activation are spatially restricted to regions of elevated oxidative stress in adrenal tissue 2. Mechanistically, JUN cooperates with other transcription factors—such as Sp1—through direct protein-protein interactions to regulate target gene promoters, exemplified by its role in 12(S)-lipoxygenase gene regulation 3. JUN expression is dynamically regulated by growth factors and cytokines, including M-CSF, which increases JUN transcript levels through both transcriptional and posttranscriptional mechanisms in monocytes 4. Clinically, JUN is a critical regulator of pathological skin scarring; its overexpression promotes hypertrophic scarring and keloid formation by modulating fibroblast populations and regulating CD36 expression 1. In aldosterone-producing adenomas, JUN activation contributes to abnormal steroidogenesis and oxidative stress dysregulation, linking it to primary aldosteronism pathogenesis 2. These findings position JUN as a central node in stress-responsive transcriptional networks underlying both normal cellular differentiation and pathological fibrotic and endocrine disorders.

Sources cited
1
JUN overexpression promotes hypertrophic skin scarring via CD36 regulation and modulation of fibroblast subpopulations; JUN is highly expressed in human scars including hypertrophic scars and keloids
PMID: 34516825
2
FOS and JUN are AP-1 transcription factors that link oxidative stress to steroidogenesis in aldosterone-producing adenomas; their phosphorylation is spatially restricted to regions of elevated oxidative stress
PMID: 41412035
3
c-Jun cooperates with Sp1 through direct interaction to regulate gene expression; c-Jun is induced downstream of MAPK activation in response to EGF and PMA
PMID: 14518567
4
M-CSF induces c-jun and jun-B gene expression in human monocytes through both transcriptional and posttranscriptional mechanisms
PMID: 1712226
⚠Limited data available — This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.56Moderate
cancerOpen Targets
0.49Moderate
Alzheimer diseaseOpen Targets
0.39Weak
colon adenocarcinomaOpen Targets
0.37Weak
colorectal adenocarcinomaOpen Targets
0.37Weak
skin squamous cell carcinomaOpen Targets
0.37Weak
Endometrial Endometrioid AdenocarcinomaOpen Targets
0.37Weak
superficial spreading melanomaOpen Targets
0.37Weak
breast neoplasmOpen Targets
0.34Weak
urinary bladder carcinomaOpen Targets
0.33Weak
melanomaOpen Targets
0.33Weak
squamous cell lung carcinomaOpen Targets
0.33Weak
hepatocellular carcinomaOpen Targets
0.31Weak
esophageal squamous cell carcinomaOpen Targets
0.30Weak
skin basal cell carcinomaOpen Targets
0.30Weak
small cell lung carcinomaOpen Targets
0.30Weak
head and neck squamous cell carcinomaOpen Targets
0.30Weak
lung adenocarcinomaOpen Targets
0.29Weak
esophageal adenocarcinomaOpen Targets
0.29Weak
gastric carcinomaOpen Targets
0.28Weak
Pathogenic Variants1
NM_002228.4(JUN):c.659del (p.Pro220fs)Pathogenic
Breast neoplasm
☆☆☆☆→ Residue 220
View on ClinVar ↗
Related Genes
CEBPGProtein interaction100%HBZProtein interaction100%PSAPProtein interaction100%JDP2Protein interaction100%CASP9Protein interaction100%CREB1Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Ovary
63%
Lung
45%
Liver
32%
Brain
19%
Heart
14%
Gene Interaction Network
Click a node to explore
JUNCEBPGHBZPSAPJDP2CASP9CREB1
PROTEIN STRUCTURE
Preparing viewer…
PDB6Y3V · 1.50 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.72LoF Tolerant
pLIⓘ
0.47Tolerant
Observed/Expected LoF0.38 [0.22–0.72]
RankingsWhere JUN stands among ~20K protein-coding genes
  • #105of 20,598
    Most Researched1,326 · top 1%
  • #4,601of 5,498
    Most Pathogenic Variants1
  • #5,498of 17,882
    Most Constrained (LOEUF)0.72
Genes detectedJUN
Sources retrieved50 papers
Response time—
📄 Sources
50▼
1
The Laboratory Rat: Relating Its Age With Human's.
PMID: 23930179
Int J Prev Med · 2013
1.00
2
Selenium and selenoproteins: it's role in regulation of inflammation.
PMID: 32144521
Inflammopharmacology · 2020
0.90
3
Epigenetic related changes on air quality.
PMID: 33891958
Environ Res · 2021
0.82
4
JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models.
PMID: 34516825
Sci Transl Med · 2021
0.80
5
Structure and function of human jun-D.
PMID: 1903194
Oncogene · 1991
0.80